Impact Partnership Wealth, LLC Myriad Genetics Inc Transaction History
Impact Partnership Wealth, LLC
- $672 Billion
- Q3 2025
A detailed history of Impact Partnership Wealth, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Impact Partnership Wealth, LLC holds 10,106 shares of MYGN stock, worth $65,284. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,106Holding current value
$65,284% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
234Shares Held
95.5MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$97.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$59.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$31.8 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$31.1 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$29.6 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $521M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...